Responses
Regular and Young Investigator Award Abstracts
Cellular Therapies
409 Development of
ex vivo
precision gene engineered B cell medicines that produce highly active and sustained levels of transgenic anti-tumor biologics
Compose a Response to This Article
Other responses
No responses have been published for this article.
